Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OSOPOLAR: UDCA for Prevention of Relapsing Complications in Gallstone Acute Pancreatitis
NCT04924868Phase 3Recruiting
- Sponsor
- Hospital General Universitario de Alicante
- Start
- Nov 2021
- Primary completion
- Jul 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ursodeoxycholic acid in cholelithiasis, acute pancreatitis (AP), sponsored by Hospital General Universitario de Alicante. Started Nov 2021; status: recruiting.
02
Drugs
ursodeoxycholic acid
03
Conditions
cholelithiasisacute pancreatitis (AP)
Beyond the preview
Go deeper on NCT04924868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04924868.